Codexis is a leading enzyme engineering company leveraging its proprietary CodeEvolver® platform to discover and develop novel, high performance enzymes and novel biotherapeutics.
Codexis enzymes have applications in the sustainable manufacturing of pharmaceuticals; in the creation of the next generation of life science tools; and as gene therapy and biologic therapeutics.
The Company’s unique performance enzymes drive improvements such as: reduced energy usage, waste generation and capital requirements; higher yields; higher fidelity diagnostics; and more efficacious therapeutics.
Codexis enzymes enable the promise of synthetic biology to improve the health of people and the planet.
|
|
|
|
|
201-500 employees
View all Codexis, Inc. employees
|
|
|
Biotechnology
|
|
|
200 Penobscot Drive, Redwood City, CA 94063, US
|
|
|
2002
|
|
|
Life Sciences, Genomics, Gene Therapy, Directed Evolution, Oligo Synthesis, Biocatalysis, Pharmaceutical Manufacturing, Enzyme Engineering, Enzyme Replacement Therapy, Api Manufacturing, Rna Manufacturing, Biocatalysts, Enzyme Optimization, Rna Detection
|
Mike Knauf is the CEO of Codexis, Inc.. To contact Mike Knauf email at [email protected].
Find accurate personal emails, work emails and phone numbers for employees
Accelerate prospecting with instant access to 350M professionals from 40M companies with the right contact details.